Digital image analysis outperforms manual biomarker assessment in breast cancer.

scientific article

Digital image analysis outperforms manual biomarker assessment in breast cancer. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/MODPATHOL.2016.34
P698PubMed publication ID26916072

P50authorJohan HartmanQ53409616
Gustav StålhammarQ61104967
P2093author name stringMattias Rantalainen
Lars Pedersen
Jonas Bergh
Nicholas P Tobin
Gustaf Rosin
Lorand Kis
Michael Lippert
Michael Grunkin
Ida Mølholm
Nelson Fuentes Martinez
P2860cites workA scaling normalization method for differential expression analysis of RNA-seq dataQ24628783
Comprehensive molecular portraits of human breast tumoursQ24630844
Is preoperative core biopsy accurate in determining the hormone receptor status in women with invasive breast cancer?Q24810878
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohortsQ25257621
edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataQ27860819
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion SequencingQ27860948
Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015Q28085062
Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-upQ28306437
HTSeq--a Python framework to work with high-throughput sequencing dataQ29614489
Diagnosis of multiple cancer types by shrunken centroids of gene expressionQ29615528
Supervised risk predictor of breast cancer based on intrinsic subtypesQ29617404
American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancerQ30494798
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013Q30543788
Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancersQ33731292
A novel model for Ki67 assessment in breast cancerQ33801255
Evaluation of Ki67 expression across distinct categories of breast cancer specimens: a population-based study of matched surgical specimens, core needle biopsies and tissue microarraysQ34466187
Long-term prognostic performance of Ki67 rate in early stage, pT1-pT2, pN0, invasive breast carcinomaQ34633934
Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011Q35130819
Membrane connectivity estimated by digital image analysis of HER2 immunohistochemistry is concordant with visual scoring and fluorescence in situ hybridization results: algorithm evaluation on breast cancer tissue microarraysQ35318918
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working groupQ35552069
Defining breast cancer intrinsic subtypes by quantitative receptor expressionQ35586697
Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patientsQ35605761
Optimizing HER2 assessment in breast cancer: application of automated image analysisQ35673706
Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoringQ36048767
Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancerQ36494250
Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population.Q37570901
Which threshold for ER positivity? a retrospective study based on 9639 patientsQ37723520
Molecular biology in breast cancer: intrinsic subtypes and signaling pathways.Q37969471
Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement.Q38061108
An international study to increase concordance in Ki67 scoringQ39037175
Observer variability in the interpretation of HER2/neu immunohistochemical expression with unaided and computer-aided digital microscopyQ39787623
The region-of-interest size impacts on Ki67 quantification by computer-assisted image analysis in breast cancer.Q40299367
Barcoding reveals complex clonal dynamics of de novo transformed human mammary cells.Q41075684
A meta-analysis on concordance between immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) to detect HER2 gene overexpression in breast cancerQ45782977
Low concordance of biomarkers in histopathological and cytological material from breast cancer.Q45937695
Template for reporting results of biomarker testing of specimens from patients with carcinoma of the breast.Q45952208
Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancersQ46372134
Intratumoral heterogeneity of HER2/neu expression and its consequences for the management of advanced breast cancerQ46755338
Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I/II melanomaQ46928169
Absolute assignment of breast cancer intrinsic molecular subtype.Q50998847
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline updateQ57130157
The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancerQ84946928
Immunohistochemical assessment of Ki67 with antibodies SP6 and MIB1 in primary breast cancer: a comparison of prognostic value and reproducibilityQ87292104
P433issue4
P921main subjectimage analysisQ860755
biomarkerQ864574
P304page(s)318-329
P577publication date2016-02-26
P1433published inModern PathologyQ15724578
P1476titleDigital image analysis outperforms manual biomarker assessment in breast cancer
P478volume29

Reverse relations

cites work (P2860)
Q47588672An inter-observer Ki67 reproducibility study applying two different assessment methods: on behalf of the Danish Scientific Committee of Pathology, Danish breast cancer cooperative group (DBCG).
Q40498847An update on the validation of whole slide imaging systems following FDA approval of a system for a routine pathology diagnostic service in the United States
Q40174538Automated histological classification of whole-slide images of gastric biopsy specimens
Q90505502Automated thresholding algorithms outperform manual thresholding in macular optical coherence tomography angiography image analysis
Q45945233Automatic cellularity assessment from post-treated breast surgical specimens.
Q89530705Cell engraftment, vascularization, and inflammation after treatment of equine distal limb wounds with endothelial colony forming cells encapsulated within hydrogel microspheres
Q90116551Commentary: Guideline for Performing Human Epidermal Growth Factor Receptor 2 Immunohistochemistry Quantitative Image Analysis well
Q37601727Construction and analysis of tissue microarrays in the era of digital pathology: a pilot study targeting CDX1 and CDX2 in a colon cancer cohort of 612 patients.
Q47321577Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer.
Q100454958Deep learning algorithms out-perform veterinary pathologists in detecting the mitotically most active tumor region
Q64066522Digital Image Analysis of BAP-1 Accurately Predicts Uveal Melanoma Metastasis
Q45943609Digital image analysis in breast pathology-from image processing techniques to artificial intelligence.
Q48212372Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement
Q90884771Digital image analysis of multiplex fluorescence IHC in colorectal cancer recognizes the prognostic value of CDX2 and its negative correlation with SOX2
Q58609581Digital image analysis supports a nuclear-to-cytoplasmic ratio cutoff value below 0.7 for positive for high-grade urothelial carcinoma and suspicious for high-grade urothelial carcinoma in urine cytology specimens
Q98945179High throughput assessment of biomarkers in tissue microarrays using artificial intelligence: PTEN loss as a proof-of-principle in multi-center prostate cancer cohorts
Q38980634Image-based surrogate biomarkers for molecular subtypes of colorectal cancer
Q38823649Immune infiltrates in the breast cancer microenvironment: detection, characterization and clinical implication
Q41666190Impact of Altering Various Image Parameters on Human Epidermal Growth Factor Receptor 2 Image Analysis Data Quality
Q96954585Independent Prognostic Value of Intratumoral Heterogeneity and Immune Response Features by Automated Digital Immunohistochemistry Analysis in Early Hormone Receptor-Positive Breast Carcinoma
Q47291975Integrated tumor identification and automated scoring minimizes pathologist involvement and provides new insights to key biomarkers in breast cancer
Q47140684Intra-tumor heterogeneity in breast cancer has limited impact on transcriptomic-based molecular profiling.
Q64115873Introduction to Digital Image Analysis in Whole-slide Imaging: A White Paper from the Digital Pathology Association
Q89657645Introduction to digital pathology and computer-aided pathology
Q58698990Ki 67 assessment in breast cancer in an Egyptian population: a comparative study between manual assessment on optical microscopy and digital quantitative assessment
Q94655415Ki-67 proliferation index in neuroendocrine tumors: Can augmented reality microscopy with image analysis improve scoring?
Q91289324Ki67 reproducibility using digital image analysis: an inter-platform and inter-operator study
Q50045468Molecular Subtypes and Local-Regional Control of Breast Cancer.
Q47104255PRL‑3 increases the aggressive phenotype of prostate cancer cells in vitro and its expression correlates with high-grade prostate tumors in patients
Q37737882Relevance of deep learning to facilitate the diagnosis of HER2 status in breast cancer
Q37453940Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers
Q38728048The role of informatics in patient-centered care and personalized medicine
Q92582860The topology of vitronectin: A complementary feature for neuroblastoma risk classification based on computer-aided detection
Q55284921Using computer assisted image analysis to determine the optimal Ki67 threshold for predicting outcome of invasive breast cancer.

Search more.